Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. - Wikidata - awgldk - TriplyDB

Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.

Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.

http://www.wikidata.org/entity/Q38727741

about

Imaging of Myocardial Fibrosis in Patients with End-Stage Renal Disease: Current Limitations and Future Possibilities Targeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training.Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease - a randomized trial.Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction.Targets for Heart Failure With Preserved Ejection Fraction.The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction.Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine.The future of pleiotropic therapy in heart failure. Lessons from the benefits of exercise training on endothelial function.Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis.Small Vessels, Big Role: Renal Microcirculation and Progression of Renal Injury.Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression - design and rationale of the STAAB cohort study.Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF).The microcirculation: a key player in obesity-associated cardiovascular disease.Heart failure with preserved ejection fraction: a nephrologist-directed primer.Inflammation and premature aging in advanced chronic kidney disease.Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.Leukocytic Toll-Like Receptor 2 Deficiency Preserves Cardiac Function And Reduces Fibrosis In Sustained Pressure Overload.Relation of Renal Function with Left Ventricular Systolic Function and NT-proBNP Level and Its Prognostic Implication in Heart Failure with Preserved versus Reduced Ejection Fraction: an analysis from the Korean Heart Failure (KorHF) Registry.Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology.N-terminal pro-B-type natriuretic peptide and prognosis in Caucasian vs. Asian patients with heart failure.Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction.Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".Congestion in acute heart failure with reduced vs. preserved left ventricular ejection fraction: differences, similarities and remaining gaps.Prognostic significance of global longitudinal strain in chronic kidney disease: the evidence is building.Publishing in a heart failure journal-where lies the scientific interest?Multiple common co-morbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress and myocardial stiffening.Immune mechanisms in heart failure.Association between suPAR and cardiac diastolic dysfunction among patients with preserved ejection fraction.Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview.

P2860

Q30360334-31751644-5BF4-44AA-B846-8DAAC665D94E Q33863759-287261AD-F198-4A10-AFFE-BC870340D9AA Q36373525-C3D83B0E-B31D-446D-8FC5-625499D9E4A2 Q37058596-418DB374-CCBB-4BF5-B840-48FC0BABE632 Q38615348-53776640-36A4-4925-B2A3-7C971C1C94FC Q38688194-3E1B1F87-E784-4C84-978E-C1F3C3339E8C Q38755320-59074857-F32C-401B-883D-D98A8AF03AF8 Q38764956-9CBCEBF0-9BBA-4B13-BB46-65813BBEF0C3 Q38768191-6B3C3E99-B94D-4260-B6DE-9EB7D1DEE7A3 Q38809793-CA8D3BE0-9F18-429D-B6B0-895E2BA4FC10 Q38959952-63C40DDA-B4DE-4169-9EC7-C9D158518CE9 Q39134052-51126CBC-5F5B-47BC-A26C-E0D948118A4B Q39159589-5E4E8834-0A72-4015-AC9B-3FDFF38E6E5F Q39268911-264381AD-BDFE-49A3-B38A-C01460822079 Q39290927-F5F42987-2522-4417-B4B0-2A6920728DED Q39301622-FDE2ABE5-0185-49B7-805D-6706D532801F Q39309490-0CF38CB3-B10B-4E2B-A9AA-79683723C23B Q41165768-86522ECD-2C8F-4EF5-8490-BDEECC00F325 Q41503928-4426A9D3-BCCA-4518-8960-1343AA19601C Q41686272-322A85FF-78EE-4E7D-9103-1854BBB37349 Q47219894-B3004F13-3C46-459B-8C6D-1A84C015EAC8 Q47338830-FF1E7FC6-F07B-4A26-91BB-D08CC37ACE28 Q47548129-8C2916E1-D6A9-4386-8181-D4C513514964 Q47739211-FB1EE64E-896F-43BA-A48E-509B936C1D5D Q47890686-6DC08B50-703B-46EA-9E00-15E7BF4F80D9 Q49203906-02E0704B-026E-419F-93AE-0FD7017635B4 Q49683363-EC6C46EC-C66E-4914-93E5-619BDFE4D900 Q49683390-854C63BC-FC06-4DE0-B3D5-EB1F7237B63F Q50048824-AE6AFE9D-4108-46FE-81A1-9B2A3F110E58 Q50061735-3C52E42B-408F-4588-B851-9CB7DC7F16DC Q50168083-A8503DE0-C0BF-4E00-8F84-26C7263FDF58 Q50955643-051E38E8-F686-4867-93A7-492E2DE63115 Q55610979-7823E4B4-8E0E-4C98-8176-3EBE853ED60F

P2860

Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.

http://www.wikidata.org/entity/Q38727741

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Connecting heart failure with ...... dysfunction and inflammation.

@en

type

label

Connecting heart failure with ...... dysfunction and inflammation.

@en

prefLabel

Connecting heart failure with ...... dysfunction and inflammation.

@en

P1433

Q38727741-D7AFBD73-96C5-4E7D-8A98-19305CF5958A

P1476

Q38727741-9A032409-EA6F-48A5-ADBB-F8C2D5F96CEF

P2093

Q38727741-04ABDAF9-D859-49B5-ACDF-5B0231CDB8B7

Q38727741-40104325-1033-4E39-988B-A8541BFCC433

Q38727741-44A09B33-C477-4F14-8C7D-98F30D56624C

Q38727741-4F88B750-CFF2-4D16-97F7-3263ADDA25C6

Q38727741-6096113B-9C80-48A2-9DBC-BE672EB6F277

Q38727741-62CAA2D6-C26C-4E61-AAA2-5DFA7EDF3D2C

Q38727741-667053C9-3EF4-48DE-BB4B-0A04FB39E094

Q38727741-9006CDFB-8D75-4B09-91A7-F4CF4608A0D1

Q38727741-99395D70-7C99-4DFA-BF4E-7DD066A4C828

Q38727741-DFFBDAEF-3F0A-4E0E-B17E-086A328E0E2A

P2860

Q38727741-00B81228-592C-4481-B5C1-C8DAC9A40DDB

Q38727741-010A39B6-B86F-4523-AC29-AF6AF897C8E7

Q38727741-09501436-DE68-4CE2-9673-A6ED557F5BDF

Q38727741-0C09F597-7F75-4B56-9006-311AD0F219EA

Q38727741-0C3A5E5E-1715-46F3-A77A-D25C9114EE58

Q38727741-0DC8DD41-F35F-4C49-81A0-9DEF4C7F47A2

Q38727741-10466160-763A-4996-92F6-FB14CA9075AF

Q38727741-13737225-6553-4F54-A9BF-29D70180D199

Q38727741-183F11AC-3C91-4262-B62D-F85DB1B3A4D3

Q38727741-1CBD3B2F-BC95-4B2E-9C49-C8B1AD02F750

P304

Q38727741-D4B6DCDF-17B3-4422-8621-2C6C3350DE77

P31

Q38727741-10E4AFE9-8D26-402D-A17F-7810326B2DD7

P356

Q38727741-69648208-CFAE-426E-BE80-2B8734DD7692

P433

Q38727741-8E440E0F-EF60-43EE-B7AF-7FF39281405A

P478

Q38727741-B1AC1C46-E1ED-42D0-BBD9-DA1A9F7AB67C

P50

Q38727741-2D055AEA-5932-446D-A383-18FFCA4AE5C2

Q38727741-85469D02-1907-4711-8FEF-EA3B6ABC73E5

P577

Q38727741-CAB34278-76F3-4DA1-AB5A-30D5EE9FB709

P698

Q38727741-447F39B8-B4BA-419F-8429-7A1418A1D450

P921

Q38727741-3B17847D-D7BE-4944-8A84-4586B59BD08A

Q38727741-C090DD9B-2AB7-4717-9500-4963575CF97A

P356

P1433

European Journal of Heart Failure

P1476

Connecting heart failure with ...... dysfunction and inflammation.

@en

P2093

Adriaan A Voors

http://www.w3.org/2001/XMLSchema#string

Caroline Cheng

http://www.w3.org/2001/XMLSchema#string

Carolyn S P Lam

http://www.w3.org/2001/XMLSchema#string

Dirk J Duncker

http://www.w3.org/2001/XMLSchema#string

Gerjan Navis

http://www.w3.org/2001/XMLSchema#string

Hans L Hillege

http://www.w3.org/2001/XMLSchema#string

Jozine M Ter Maaten

http://www.w3.org/2001/XMLSchema#string

Kevin Damman

http://www.w3.org/2001/XMLSchema#string

Loek van Heerebeek

http://www.w3.org/2001/XMLSchema#string

Walter J Paulus

http://www.w3.org/2001/XMLSchema#string

P2860

Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis

Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

Cardiac nonmyocytes in the hub of cardiac hypertrophy

NAD(P)H oxidase: role in cardiovascular biology and disease

Plasma sodium stiffens vascular endothelium and reduces nitric oxide release.

Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure.

Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology

Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.

Microvascular rarefaction: the decline and fall of blood vessels

P304

588-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJHF.497

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Marianne C. Verhaar

Carolyn S P Lam

P577

2016-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26861140

http://www.w3.org/2001/XMLSchema#string

P921